Clinical Trial: Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07239440) titled 'Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control' on Nov. 16.

Brief Summary: This study is a multicenter, double-blind, active-controlled, randomized, parallel clinical trial to evaluate the efficacy and safety of DA-2811 when added to ongoing BT-1 and BT-2 combination therapy in patients with type 2 diabetes who have inadequate glycemic control

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Diabete Mellitus

Intervention: DRUG: DA-2811

DA-2811 + DA-2811-R2, orally, once...